Afrocentric InvestmentJSE:ACT 52 Current Ratio is 1.13 as of Dec. 2025, which is 28% below its 10-year median of 1.57. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.09 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Afrocentric Investment ranks worse than 66.62% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Afrocentric Investment's current ratio for the quarter that ended in Dec. 2025 was 1.13.
Afrocentric Investment has a current ratio of 1.13. It generally indicates good short-term financial strength.
The historical rank and industry rank for Afrocentric Investment's Current Ratio or its related term are showing as below:
JSE:ACT'
s Current Ratio Range Over the Past 10 Years
Min: 1.13 Med: 1.57 Max: 2.31
Current: 1.13
During the past 13 years, Afrocentric Investment's highest Current Ratio was 2.31. The lowest was 1.13. And the median was 1.57.
JSE:ACT's Current Ratio is ranked worse than 66.62% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs JSE:ACT: 1.13
Afrocentric Investment (JSE:ACT) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Afrocentric Investment Current Ratio Related Terms
Afrocentric Investment Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:ACT vs HCA, THC, DVA: Current Ratio Comparison
For the Medical Care Facilities subindustry, Afrocentric Investment's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Current Ratio distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Afrocentric Investment (JSE:ACT) has a Current Ratio of 1.13 as of Dec. 2025. This is 28% below median its historical median of 1.57. Over the past decade, Afrocentric Investment's Current Ratio has ranged from 1.13 to 2.31. According to the industry distribution chart, Afrocentric Investment ranks #455 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 66.6%.
Is Afrocentric Investment's Current Ratio too high?
Afrocentric Investment's current Current Ratio of 1.13 is 28% below median its 10-year median of 1.57. Over the past 10 years, this metric has ranged from a low of 1.13 to a high of 2.31. The Healthcare Providers & Services industry median Current Ratio is 1.47. Afrocentric Investment's value of 1.13 is 23.1% below this industry median. Based on the distribution chart, Afrocentric Investment ranks #455 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's Current Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #455 out of 683 companies for Current Ratio. This places Afrocentric Investment in the lower half of its industry. The industry median Current Ratio is 1.47. Afrocentric Investment's value of 1.13 is 23.1% below this benchmark. Historically, Afrocentric Investment's own Current Ratio has ranged from 1.13 to 2.31 over the past decade. While the company's 10-year median is 1.57 vs. the industry median of 1.47, Afrocentric Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afrocentric Investment's current Current Ratio of 1.13 is 23.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current Current Ratio is 1.13, which is 28% below median its own 10-year median of 1.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.09, compared to a current price of R0.79 — trading 62.2% below its estimated fair value. The current Current Ratio is 1.13, which is 28% below median its 10-year median of 1.57 and 23.1% below the Healthcare Providers & Services industry median of 1.47. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current Current Ratio is 1.13 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.79 is trading 62.2% below its estimated GF Value™ of R2.09.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
Current Ratio: 1.13 (28% below median its 10-year median of 1.57)
GF Value™: R2.09 vs. price of R0.79 (62.2% below fair value)
Industry Position: 23.1% below the Healthcare Providers & Services median (#455 of 683)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score
Get the complete analysis for JSE:ACT
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
